Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

Published:2024-02 Issue:2 Volume:9 Page:347-355
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Koshino Akihiko,Neuen Brendon L.,Oshima Megumi,Toyama Tadashi,Hara Akinori,Arnott Clare,Neal Bruce,Jardine Meg,Badve Sunil V.,Mahaffey Kenneth W.,Pollock Carol,Hansen Michael K.,Wada Takashi,Heerspink Hiddo J.L.

Funder

Japan Society for the Promotion of Science

Janssen Research and Development

Publisher

Elsevier BV

Subject

Nephrology

Reference27 articles.

1. Chronic kidney disease and the risk of end-stage renal disease versus death;Dalrymple;J Gen Intern Med,2011

2. Diabetes with early kidney involvement may shorten life expectancy by 16 years;Wen;Kidney Int,2017

3. The promise of tubule biomarkers in kidney disease: a review;Ix;Am J Kidney Dis,2021

4. Effect of autoantibodies to erythropoietin receptor in systemic lupus erythematosus with biopsy-proven lupus nephritis;Hara;J Rheumatol,2016

5. Clinical and pathological significance of autoantibodies to erythropoietin receptor in type 2 diabetic patients with CKD;Hara;Kidney Int Rep,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP